Flecainide is a synthetic class Ic antiarrhythmic agent that selectively blocks cardiac sodium channels, slowing conduction velocity and prolonging the refractory period in the atria and ventricles. It is primarily utilized in pharmaceutical research, analytical testing, and as a reference standard for quality control in the development of medications for supraventricular arrhythmias (e.g., atrial fibrillation) and certain ventricular tachycardias. Flecainide is effective in patients without significant structural heart disease and is often studied in electrophysiology research to understand arrhythmia mechanisms. It is supplied as a high-purity powder (≥95%) for laboratory use, not for direct therapeutic administration. Chemical formula: C₁₇H₂₀F₆N₂O₃; molecular weight: 414.35.